You're reading the free version. Trader adds the live tape and alerts.
Start tracking
XENE Sale Disclosure
Kenney Christopher John · SEC Form 4 · Filed Aug 31, 2026
Sale
Calculated transaction value
$383.15K
Kenney Christopher John Chief Medical Officer
XENE
Transaction date
Aug 28, 2026
Public filing date
Aug 31, 2026
Filing lag
Filed 3 days later
XENE daily price context
Close on/before transaction
$59.99
Aug 28, 2026
First close after public filing
$60
Sep 1, 2026
30-day return after filing
-38.02%
Through Sep 30, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 6,368 shares @ $60.17
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-377309
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$425.83K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Xenon Pharmaceuticals Inc. XENE | Sale | Aug 28, 2026 | $42.68K |
| Xenon Pharmaceuticals Inc. XENE Current | Sale | Aug 28, 2026 | $383.15K |